FDA Approved: MEPSEVII — Original Application (Ultragenyx Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved Mepsevii (vestronidase alfa) as an original Biologics License Application for the treatment of mucopolysaccharidosis type VII (Sly syndrome). T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Vii

Drugs mentioned

• Mepsevii (vestronidase alfa)

Snippet

ORIG AP for MEPSEVII (VESTRONIDASE ALFA)